In male mice and in men, estrogen deficiency due to defects in the aromatase gene leads to insulin resistance, glucose intolerance, and increased risk of developing T2D, which can be improved by estrogen therapy [127,132]. Here, CYP19A1 is linked to Glucose intolerance.